Sutures, tapes, glues, sealants — trends in wound closure

Closure of acute and traumatic wounds is a $10.5 billion global market, of which the USA represents 34%. The bulk (75%) of revenues in wound closure — despite a flurry of new closure products ranging from synthetic to biological — remains in physical wound closure products like sutures, staples, clips and tapes, but the trend away from these has been clear for some time.

Advanced wound closure technologies including fibrin and other sealants and high-strength glues bring the potential to reduce scarring, heal wounds faster, reduce infection, reduce blood loss (provide for both closure and hemostasis) and provide other benefits. The challenge for these products is that they must meet head-on the performance of traditional wound closure types like sutures, which are fundamentally ingrained in the surgeons’ skill sets and provide unquestionably strong closure.

Below is illustrated the growth in wound closure revenues by type through 2017 reflecting, in the aggregate, the continued growing demand for closure technologies (despite economics, healthcare reform or any other market forces).

Source: MedMarket Diligence, LLC; Report #S190.

The share of the total market represented by sutures, staples, mechanical closure and tapes is declining steadily as manufacturers of sealants, glues and related products have succeeding in progressively chipping away at the performance gap with sutures and related products. This is illustrated below in the figures of each product’s share of the total wound closure market in the U.S.

Source: MedMarket Diligence, LLC; Report #S190.

Leave a Reply